Keyphrases
Metformin
100%
Metabolic Changes
100%
Lymphoma Cells
100%
Venetoclax
100%
Bcl-2 Inhibitor
100%
CDK9 Inhibitor
100%
IC50 Value
33%
Diffuse Large B-cell Lymphoma (DLBCL)
33%
Daudi
33%
Phosphoinositide 3-kinase (PI3K)
22%
Lymphoma
22%
Antitumor Effect
22%
Idelalisib
22%
In Cancer
11%
Cyclin-dependent Kinase
11%
Kinase Inhibitor
11%
Cancer Cells
11%
Mitochondrial Electron Transport Chain
11%
Bcl-2 Family Proteins
11%
Mitochondrial Metabolism
11%
High Concentration
11%
Mammalian Target of Rapamycin (mTOR)
11%
Mitochondrial Oxidative Metabolism
11%
Cellular Metabolism
11%
Glycolytic Metabolism
11%
Novel Agents
11%
Pro-survival
11%
Effective Compounds
11%
AMP-activated Protein Kinase
11%
Germinal Center
11%
Novel Combinations
11%
Double Hit
11%
Potentiating Effect
11%
Mantle Cell Lymphoma
11%
Burkitt
11%
Mitochondrial Physiology
11%
Targeting Cancer
11%
Cancer Metabolism
11%
JeKo-1 Cells
11%
Medicine and Dentistry
Lymphoma Cell
100%
Glycon
100%
Venetoclax
100%
Diffuse Large B-Cell Lymphoma
33%
Cell Line
33%
Idelalisib
22%
Inositol Phosphate
22%
Neoplasm
11%
Cancer Cell
11%
Phosphotransferase
11%
Cell Metabolism
11%
Germinal Center
11%
Phosphotransferase Inhibitor
11%
Protein Bcl 2
11%
Cyclic AMP Dependent Protein Kinase
11%
Mantle Cell Lymphoma
11%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
11%
Respiratory Chain
11%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
mTOR Signaling
11%
Cyclin-Dependent Kinase
11%
Cancer Metabolism
11%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Venetoclax
100%
Diffuse Large B Cell Lymphoma
33%
Malignant Neoplasm
22%
Inositol Phosphate
22%
Idelalisib
22%
Cyclic AMP Dependent Protein Kinase
11%
Phosphotransferase Inhibitor
11%
Phosphotransferase
11%
Protein Bcl 2
11%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
11%
Cyclin Dependent Kinase
11%
Neoplasm
11%
Mantle Cell Lymphoma
11%